Health Science Reports (Nov 2023)
High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
Abstract
No abstracts available.Keywords
Health Science Reports (Nov 2023)